These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3794713

  • 1. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury.
    Altar CA, Marien MR, Marshall JF.
    J Neurochem; 1987 Feb; 48(2):390-9. PubMed ID: 3794713
    [Abstract] [Full Text] [Related]

  • 2. Preservation of dopamine release in the denervated striatum.
    Altar CA, Marien MR.
    Neurosci Lett; 1989 Jan 30; 96(3):329-34. PubMed ID: 2497410
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW, Slimovitch C, Toffano G.
    Br J Pharmacol; 1990 Apr 30; 99(4):741-9. PubMed ID: 2361171
    [Abstract] [Full Text] [Related]

  • 4. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.
    Hefti F, Enz A, Melamed E.
    Neuropharmacology; 1985 Jan 30; 24(1):19-23. PubMed ID: 2858830
    [Abstract] [Full Text] [Related]

  • 5. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A, Nissbrandt H.
    Neuropharmacology; 1992 Jul 30; 31(7):661-70. PubMed ID: 1328918
    [Abstract] [Full Text] [Related]

  • 6. Striatal 3-methoxytyramine as an index of dopamine release effects of electrical stimulation.
    Wood PL, Nair NP, Bozarth M.
    Neurosci Lett; 1982 Oct 23; 32(3):291-4. PubMed ID: 6294566
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA, Boylan CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C.
    J Neurochem; 1994 Sep 23; 63(3):1021-32. PubMed ID: 7519657
    [Abstract] [Full Text] [Related]

  • 8. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
    Brannan T, Bhardwaj A, Martinez-Tica J, Weinberger J, Yahr M.
    J Neural Transm Park Dis Dement Sect; 1990 Sep 23; 2(1):15-22. PubMed ID: 2113388
    [Abstract] [Full Text] [Related]

  • 9. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system.
    Robinson TE, Mocsary Z, Camp DM, Whishaw IQ.
    J Neurosci; 1994 May 23; 14(5 Pt 1):2687-96. PubMed ID: 7514209
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E, Hefti F, Wurtman RJ.
    Proc Natl Acad Sci U S A; 1980 Jul 23; 77(7):4305-9. PubMed ID: 6254020
    [Abstract] [Full Text] [Related]

  • 12. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H, Carlsson A.
    J Neurochem; 1987 Sep 23; 49(3):959-67. PubMed ID: 3612134
    [Abstract] [Full Text] [Related]

  • 13. Effect of repeated electroconvulsive shock on striatal L-dopa and dopamine metabolism: an in vivo study.
    Brannan T, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1993 Sep 23; 6(1):35-44. PubMed ID: 7692872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-dopa.
    Brannan T, Knott P, Kaufmann H, Leung L, Yahr M.
    J Neural Transm; 1989 Sep 23; 75(2):149-57. PubMed ID: 2918307
    [Abstract] [Full Text] [Related]

  • 16. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ, Tilson HA, Nanry KP, Hudson PM, Hong JS, Stachowiak MK.
    Brain Res; 1988 Oct 04; 461(2):335-42. PubMed ID: 3141002
    [Abstract] [Full Text] [Related]

  • 17. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats.
    Altar CA, O'Neil S, Marshall JF.
    Neuropharmacology; 1984 Mar 04; 23(3):309-18. PubMed ID: 6427648
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.